Airway ultrasound to find lung blood clots in critically ill patients
Tests airway ultrasound to spot lung clots in critically ill adults.
Key facts
- Who runs it
- University of California, Los Angeles
- Where
- Los Angeles and Santa Monica, United StatesSee the 2 sites
- Trial code
- Registry title
- Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients
- Status
- Enrolling by invitation
- People taking part
- 60 people, planned
- Started
- 12 Aug 2019
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Endobronchial ultrasound (EBUS)
- Record updated
- 6 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in intensive care on a breathing tube who may have, or have, a sudden blood clot in the lungs (acute pulmonary embolism). A substudy is looking for adults on a breathing tube who are having a bronchoscopy (a camera test of the airways) as part of their usual care.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Main study: suspected or confirmed acute pulmonary embolism in patients in intensive care who have a breathing tube. Substudy: patients with a breathing tube who are having a bronchoscopy as part of their usual care.
Main reasons for not taking part
- The treating doctor finds the person cannot have a bronchoscopy
- Breathing tube smaller than 8.0 mm
- Reasons the person cannot be given lidocaine
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Patient ≥ 18 years of age
- The patient or patient's surrogate must understand and sign informed consent form (ICF)
- Intubated patients in the intensive care unit (ICU) where there is a clinical concern for acute pulmonary embolism or a confirmed diagnosis for acute pulmonary embolism
- Patient ≥ 18 years of age
- The patient or patient's surrogate must understand and sign informed consent form (ICF)
- Intubated patients undergoing clinical bronchoscopy, as determined by the treating physician
Who cannot take part
- Contraindications to lidocaine; Retrospective Chart Review:; Of the 60 total subjects enrolled in the study, media including images and videos that are previously recorded for 20 patients who underwent a clinical bronchoscopy with EBUS as a part of their standard of care will also be available to our research team without consent from the patient to help supplement the data we obtain from the 20 subjects that are enrolled in the pulmonary vascular mapping substudy
- Patient does not meet the requirements to undergo clinical bronchoscopy, as determined by the treating physician
- Endotracheal tube size less than 8.0 mm
- Contraindications to lidocaine; Pulmonary Vascular Mapping Substudy:; Enrollment for the pulmonary vascular mapping substudy will be based on the following inclusion and exclusion criteria:
- Patient does not meet the requirements to undergo clinical bronchoscopy, as determined by the treating physician
- Endotracheal tube size less than 8.0 mm
Where in United States
- Ronald Reagan UCLA Medical CenterLos Angeles, United StatesEnrolling by invitation
- UCLA Medical Center, Santa MonicaSanta Monica, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Acute pulmonary embolism (PE) in critically ill patients is common and often life threatening. The diagnosis of acute PE is often entertained in intensive care unit patients who develop unexplained hypotension or hypoxemia. Obtaining diagnostic confirmation of acute PE with a contrast-enhanced computed tomography of the chest (CT angiogram) may be difficult as patients are often too unstable for transport to the CT scanner or have renal insufficiency limiting the ability to receive intravenous contrast agents. Making or excluding the diagnosis of acute PE in these patients is critically important, as hemodynamic instability or right heart dysfunction, if due to PE, puts patients in the massive or submassive category and increased mortality risk. More aggressive therapies such as thrombolysis, extracorporeal membrane oxygenation or surgical embolectomy are often entertained. The investigators have previously described a case where endobronchial ultrasound (EBUS) was employed in the diagnostic algorithm of suspected acute PE and significantly affected treatment recommendations. The investigators believe that, in these patients, use of EBUS to assess for thrombotic occlusion of the central pulmonary vasculature can fill a critical gap in the decision tree for management of these patients.
Read full original descriptionShow less
EBUS has become part of the diagnostic approach in a number of clinical situations, including the workup and staging of suspected malignancy, unexplained lymphadenopathy, and diagnosis of mediastinal and parabronchial masses. There is strong evidence that EBUS is equivalent to mediastinoscopy in the mediastinal staging of lung cancer. The number of physicians skilled and experienced in performance of EBUS has increased dramatically, and training in the procedure is frequently obtained in a pulmonary fellowship.
To our knowledge, there have been no prospective studies that investigate the use of EBUS as a tool for the diagnosis of acute central pulmonary embolism in critically ill patients where obtaining diagnostic confirmation of this diagnosis with a contrast-enhanced computed tomography of the chest is not safe or feasible.
The 3 groups in the trial
- Critically Ill PatientsTreatment being tested
Intubated patients in the intensive care unit (ICU) where there is a clinical concern for acute pulmonary embolism or a confirmed diagnosis for acute pulmonary embolism. The enrolled subjects will be imaged using the flexible bronchoscopy with EBUS.
Treatment: Endobronchial ultrasound (EBUS)
- Patients undergoing standard of care clinical bronchoscopyTreatment being tested
Patients undergoing clinical bronchoscopy as a part of their standard of care. The enrolled subjects will be imaged using the flexible bronchoscopy with EBUS.
Treatment: Endobronchial ultrasound (EBUS)
- Previously recorded patient media from standard of care clinical bronchoscopy with EBUSNo study treatment, for comparison
Patients who underwent a standard of care clinical bronchoscopy with EBUS previously. Information and media including images and videos that were previously recorded for patients who underwent a standard of care clinical bronchoscopy with EBUS will be available to the study team.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pilot Study to Evaluate the Role of Endobronchial Ultrasound (EBUS) in the Diagnosis of Acute Pulmonary Embolism in Critically Ill Patients
- Plain-language title
- Airway ultrasound to find lung blood clots in critically ill patientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 6 May 2026